BioCentury
ARTICLE | Clinical News

Boehringer unveils diabetes pipeline

October 18, 2008 1:36 AM UTC

Boehringer Ingelheim (Ingelheim, Germany) announced its entrance into the Type II diabetes drug development space as it unveiled three products in late-stage testing. The compounds include: Ondero ( B...